| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/14/2009 | US20090123478 Human antibody molecules for IL-13 |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation |
| 05/14/2009 | CA2703996A1 Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/14/2009 | CA2703994A1 Use of vitamin d receptor agonists and precursors to treat fibrosis |
| 05/14/2009 | CA2703987A1 Cyclobutyl carboxylic acid derivatives |
| 05/13/2009 | EP2058309A1 Fused heterocyclic compound |
| 05/13/2009 | EP2058293A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/13/2009 | EP2057173A1 Amides as sphingomyeline inhibitors |
| 05/13/2009 | EP2057124A2 Compounds and compositions as itpkb inhibitors |
| 05/13/2009 | EP2056862A2 Parathyroid hormone analogues and uses thereof |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1317536B1 Tnf receptor-like molecules and uses thereof |
| 05/13/2009 | EP1115743B1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 05/13/2009 | CN101432281A 6-o-substituted benzoxazole and benzothiazole compounds and methods of inhibiting CSF-1R signaling |
| 05/13/2009 | CN101432010A Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells |
| 05/13/2009 | CN101431999A Use of VX-702 for treating rheumatoid arthritis |
| 05/13/2009 | CN101428126A Externally used medicinal liquor for massaging spondyle |
| 05/13/2009 | CN101428123A Medicament composition for treating hydrarthrosis and cyst, and preparation method thereof |
| 05/13/2009 | CN101428119A Pillow for treatment of cervical spondylopathy |
| 05/13/2009 | CN101428096A Chinese medicinal composition for treating femoral head necrosis and preparation method thereof |
| 05/13/2009 | CN101428088A Hyperosteogeny treating medicine ointment |
| 05/13/2009 | CN101428079A Chinese-medicinal wine for treating cervical vertebra disease |
| 05/13/2009 | CN101428061A Medicament for treating psoriasis, skin stubborn dermatitis |
| 05/13/2009 | CN101428056A Health care formulation for improving osteoporosis of female in middle and old age and preparation method thereof |
| 05/13/2009 | CN101428052A Method for extracting radix gynurae segeti alkaloid with supercritical carbonic anhydride |
| 05/13/2009 | CN101428051A Externally used medicament for treating bone fracture |
| 05/13/2009 | CN101428016A Uses of di-indole methyl hydride and its derivant in treating rheumatoid arthritis |
| 05/13/2009 | CN100486996C Antibodies to human MCP-1 |
| 05/13/2009 | CN100486641C Compound bone peptide medicine composition oral preparation and preparation method therefor |
| 05/13/2009 | CN100486622C Medicated pad |
| 05/13/2009 | CN100486614C Medication for treating disease of proplapse of lumbar intervertebral disc |
| 05/13/2009 | CN100486590C A high milk calcium granule |
| 05/13/2009 | CN100486576C Substituted pyridinones as modulators of P38MAP kinase |
| 05/13/2009 | CN100486573C Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and use |
| 05/13/2009 | CN100486558C Composite whitening spot-dispelling liquid and its production |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531633 Immunotherapy against infection; harvesting antibodies directed against Staphylococcus from blood of immunized subject for use as immunotherapeutic agents |
| 05/12/2009 | US7531571 4-benzyl-2-phenylchroman skeleton with hydroxyl substitutions compounds; estrogen beta -receptors (ER beta ) modulator; hormone replacement therapy; osteoporosis, postmenopause; side effect reduction |
| 05/12/2009 | US7531564 Substituted benzoxazoles as estrogenic agents |
| 05/12/2009 | US7531549 2-[(2-Isopropylsulfanyl-3-oxo-spiro[3.5]non-1-en-1-yl)amino]-3-[4-([2,7]naphthyridin-1-ylamino)phenyl]propanoic acid; compounds can inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 05/12/2009 | US7531539 Inhibit tyrosine kinase activity of Trk receptors; antiproliferative agents, anticancer agents; cancer, psoriasis or rheumatoid arthritis; N4-pyrazol-5-yl-pyrrolo[2,1-f] [1,2,4]triazine-2,4-diamines |
| 05/12/2009 | US7531536 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 05/12/2009 | US7531531 Method of treating diseases associated with altered kinase activity with bicyclo-pyrazoles |
| 05/12/2009 | US7531527 (20R)-1 alpha ,25-dihydroxy-2-[3'-hydroxypropylidene]-19-norvitamin D3; high intestinal calcium transport activity; ability to mobilize calcium from bone; bone replacement surgeries, autoimmune diseases, multiple sclerosis, diabetes mellitus,lupus, antiproliferative agents |
| 05/12/2009 | US7531526 Boronic ester and acid compounds, synthesis and uses |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | CA2356080C Improved formulation for transportation of corticosteroid through pores of a barrier |
| 05/12/2009 | CA2334875C Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome |
| 05/07/2009 | WO2009058076A1 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase |
| 05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
| 05/07/2009 | WO2009057287A1 Food material for inhibiting the formation of osteoclast |
| 05/07/2009 | WO2009057282A1 Food material for inhibiting bone resorption |
| 05/07/2009 | WO2009057281A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | WO2009057280A1 Bone-strengthening food material |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056692A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/07/2009 | WO2009056582A1 Novel compounds |
| 05/07/2009 | WO2009056268A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | WO2009039175A3 Method for inhibiting bone resorption |
| 05/07/2009 | WO2009035265A3 Calcium phosphate microspheres drug delivery system and process for preparing the same |
| 05/07/2009 | WO2008103314A3 Methods for modulating bone formation and mineralization |
| 05/07/2009 | WO2007067364A3 Methods of treating cancer and other conditions or disease states using l-cytosine nucleoside analogs |
| 05/07/2009 | US20090118685 Medicated sleeve |
| 05/07/2009 | US20090118369 Use of CIS-9, Trans-11 Isomer of Conjugated Lineoleic Acid |
| 05/07/2009 | US20090118348 Drug-introduced photo-crosslinked hyaluronic acid derived gel |
| 05/07/2009 | US20090118330 Diurea derivatives |
| 05/07/2009 | US20090118316 Methods for Augmenting Bone |
| 05/07/2009 | US20090118313 Treating atherosclerosis by administering 1-(N-(2-(diethylamino)ethyl)-N-(4-(4-trifluoromethylphenyl)benzyl)aminocarbonylmethyl)-2-(4-fluorobenzyl)thio-5,6-trimethylenepyrimidin-4-one or a salt; coadministering an antioxidant probucol; inhibitor of platlet activating factor acetylhydrolase |
| 05/07/2009 | US20090118298 Octahydropentalene compounds as chemokine receptor antagonists |
| 05/07/2009 | US20090118268 OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS |
| 05/07/2009 | US20090118252 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118251 Transdermal formulation containing androgen, macrocyclic ester or ketone enhancer and thickener; extended time high blood serum concentration; rapidly absorbed gel; treatment of male hypogonadism |
| 05/07/2009 | US20090118250 Pharmaceutical composition |
| 05/07/2009 | US20090118239 Amorphous and crystalline forms of ibandronate disodium |
| 05/07/2009 | US20090118229 Carotenoid-containing compositions and methods |
| 05/07/2009 | US20090118199 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 05/07/2009 | US20090118192 sequentially administering parathyroid hormone and bone resorption inhibitor; bone disorders; osteoporosis |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117652 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117131 Pharmaceutical Composition for The Treatment or Prevention of Allergic Diseases, Use Thereof, and A Method for The Treatment or Prevention of Allergic Diseases |
| 05/07/2009 | US20090117118 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 05/07/2009 | US20090117107 Molecular targets and compounds, and methods to identify the same, useful in the treatment of bone and joint degenerative diseases |
| 05/07/2009 | US20090117070 Methods and Crosslinked Polymer Compositions for Cartilage Repair |
| 05/07/2009 | US20090117037 Methods Of Treatment Using CTLA-4 Antibodies |
| 05/07/2009 | DE102007051914A1 Verfahren zur Herstellung von mit Wachstumsfaktoren beladenen Partikeln sowie die so erhaltenen Partikel A process for preparing loaded with growth factors, as well as particles, the particles thus obtained |
| 05/07/2009 | DE10010113B4 Natives Schwammkollagen, Verfahren zu seiner Isolierung und seine Verwendung, sowie natives nanopartikuläres Schwammkollagen, Verfahren zu seiner Herstellung und seine Verwendung Native collagen sponge, process for its isolation and its use, as well as native nanoparticulate sponge collagen, process for its preparation and its use |
| 05/07/2009 | CA2739011A1 Osteoarthritis gene therapy |
| 05/07/2009 | CA2704296A1 An antigen associated with rheumatoid arthritis |
| 05/07/2009 | CA2704221A1 Bone-reinforcing food material |
| 05/07/2009 | CA2704190A1 Nell-1 compositions |
| 05/07/2009 | CA2704144A1 Food material for promoting the differentiation of osteoblast and inhibiting the differentiation of osteoclast |
| 05/07/2009 | CA2704092A1 Food material for inhibiting osteoclastogenesis |